The Adult Shingles Vaccine: Challenges of Delivery
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
A vaccine for adult Shingles was officially licensed for use in 2006, but recent data shows that delivery of this vaccination has been a challenge. What are some of the issues which are limiting the distribution of the Shingles vaccine? How can we best address these difficulties? For expert insight on these questions and more, host Dr. Mark Nolan Hill welcomes Dr. Michael Oxman, professor of medicine and pathology at the University of California, San Diego School of Medicine, and Dr. William Schaffner, professor and chair of preventive medicine and professor of medicine in the department of infectious diseases at Vanderbilt University School of Medicine.
Overview
A vaccine for adult Shingles was officially licensed for use in 2006, but recent data shows that delivery of this vaccination has been a challenge. What are some of the issues which are limiting the distribution of the Shingles vaccine? How can we best address these difficulties? For expert insight on these questions and more, host Dr. Mark Nolan Hill welcomes Dr. Michael Oxman, professor of medicine and pathology at the University of California, San Diego School of Medicine, and Dr. William Schaffner, professor and chair of preventive medicine and professor of medicine in the department of infectious diseases at Vanderbilt University School of Medicine.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
NYHA FC and Finerenone Response: Clinical Trial Insights
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?